Integrating necroptosis into pan-cancer immunotherapy: a new era of personalized treatment
IntroductionNecroptosis has emerged as a promising biomarker for predicting immunotherapy responses across various cancer types. Its role in modulating immune activation and therapeutic outcomes offers potential for precision oncology. MethodsA comprehensive pan-cancer analysis was performed using b...
Saved in:
| Main Authors: | Yan Gao, Sheng Chen, Lei Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1510079/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SERPINA1 is a new frontier in cancer immunotherapy and drug targeting by pan-cancer analysis
by: Chen Fu, et al.
Published: (2025-06-01) -
Construction and validation of a necroptosis-related lncRNA signature for predicting the prognosis of gastrointestinal cancer patients
by: Weicheng Huang, et al.
Published: (2025-08-01) -
Mechanism and relevance of necroptosis to immune microenvironment of periodontitis: A pilot study
by: ZHENG Zhanglong, et al.
Published: (2023-10-01) -
Integrative pan-cancer analysis and experiment validation identified GLS as a biomarker in tumor progression, prognosis, immune microenvironment, and immunotherapy
by: Dongming Li, et al.
Published: (2025-01-01) -
Pan-cancer analysis and single-cell analysis identifies the CENPN as a biomarker for survival prognosis and immunotherapy
by: Nie Zhang, et al.
Published: (2025-01-01)